Emerald Coast Hospital Group Recognized as Top French Hospital for Clinical Trials

The Clinical Research Unit of the Rance Émeraude Hospital Group (GHRE) in Ille-et-Vilaine, France, has been awarded the prize for the best French general hospital center “influencer 2025” by the French-speaking Federation of Digestive Cancerology (FFCD). The award, presented on January 23, 2026, recognizes the GHRE as the leading French general hospital for including patients in FFCD clinical trials, surpassing centers in La Roche-sur-Yon and Perpignan.

GHRE’s Success in Clinical Trial Enrollment

The Rance Émeraude Hospital Group distinguished itself by enrolling the highest number of patients in clinical trials conducted by the FFCD among all general hospitals in France. Ille-et-Vilaine is home to 19 hospitals and clinics.

About the Rance Émeraude Hospital Group

The Rance Émeraude Hospital Group is a key healthcare provider in the region, contributing significantly to medical research and patient care. Hospitals and Clinics in Ille-et-Vilaine include facilities in Rennes, Saint-Malo, Fougères, and Vitré.

The French-speaking Federation of Digestive Cancerology (FFCD)

The FFCD plays a crucial role in advancing research and treatment for digestive cancers. Their recognition of the GHRE highlights the hospital group’s commitment to improving outcomes for patients with these conditions.

Ille-et-Vilaine Healthcare Landscape

Ille-et-Vilaine, a department in the Brittany region of France, boasts a network of healthcare facilities. Centres Hospitaliers in Ille-et-Vilaine include facilities in Combourg, Fougères, Redon, and Saint-Malo.